Induction ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsLymphomaChemotherapy, AdjuvantLymphoma, Non-HodgkinCombined Modality TherapyCisplatinLymphoma, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, T-CellTreatment OutcomeRemission InductionCyclophosphamideDoxorubicinCarcinoma, Large CellAntineoplastic AgentsDisease-Free SurvivalEtoposideSurvival AnalysisNeoplasm StagingLymphoma, FollicularLung NeoplasmsNeoadjuvant TherapySurvival RatePrognosisCytarabineBurkitt LymphomaVincristineCarboplatinTaxoidsPaclitaxelDrug Administration ScheduleHead and Neck NeoplasmsCarcinoma, Squamous CellLeukemia, Myeloid, AcuteMethotrexateIfosfamideLymphoma, B-Cell, Marginal ZoneHodgkin DiseaseDaunorubicinBleomycinCarcinoma, Non-Small-Cell LungVinblastineBreast NeoplasmsAntigens, CD30Neoplasm Recurrence, LocalRadiotherapy, AdjuvantTransplantation, AutologousLymphoma, T-Cell, PeripheralSalvage TherapyLymphoma, T-Cell, CutaneousPrecursor Cell Lymphoblastic Leukemia-LymphomaFollow-Up StudiesRadiotherapyFluorouracilDeoxycytidineLymphoma, AIDS-RelatedChemoradiotherapyLymphoma, Mantle-CellTime FactorsCarcinoma, NeuroendocrineRadiotherapy DosageKaplan-Meier EstimateAntimetabolites, AntineoplasticEnzyme InductionIdarubicinDrug Resistance, NeoplasmLeukemia, MyeloidNeutropeniaTesticular NeoplasmsAdenocarcinomaPrednisoneMelphalanProspective StudiesGranulocyte Colony-Stimulating FactorImmunohistochemistryTumor Markers, BiologicalLaryngectomyLymphoma, Large-Cell, ImmunoblasticHematopoietic Stem Cell TransplantationHypopharyngeal NeoplasmsOrganoplatinum CompoundsLymphoma, Large-Cell, AnaplasticRecurrenceNasopharyngeal NeoplasmsNeoplasm MetastasisMitoxantroneAnthracyclinesAntibodies, MonoclonalDose-Response Relationship, DrugNeoplasmsVindesineBone MarrowTranslocation, GeneticCell Line, TumorAsparaginaseAntibiotics, AntineoplasticThiotepaNeoplasms, Germ Cell and EmbryonalCranial Irradiation